An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis

Pharmacology, Toxicology and Pharmaceutical Science

• Cancer Growth 100%
• Prostate Cancer 100%
• Plant Extract 100%
• Rat 100%
• Neoplasm 33%
• Tumor Growth 33%
• Enzymes 33%
• Hyaluronidase 33%
• IC50 16%
• Caspase 16%
• Antitumor Activity 16%
• Proteinase 16%
• Antiinfective Agent 16%
• Tumor Model 16%
• Cancer Incidence 16%
• Castration Resistant Prostate Cancer 16%
• Lung Metastasis 16%
• Antiproliferative Activity 16%
• Hyaluronic Acid 16%
• Cytotoxicity 16%

Immunology and Microbiology

• Plant Extract 100%
• Rat 100%
• Cell Line 33%
• Cell Proliferation 33%
• Gel Filtration Chromatography 33%
• Programmed Cell Death 33%
• In Vitro 33%
• Immune Response 16%
• Cell Death 16%
• Caspase 16%
• Cancer Cell 16%
• IC50 16%
• Cytotoxicity 16%
• Molecular Weight 16%
• Antineoplastic Activity 16%
• Extracellular Matrix 16%
• Prostate 16%
• Antiproliferative Activity 16%
• Cell Cycle G1 Phase 16%
• Cell Cycle Phase 16%
• Cancer Incidence 16%
• Ultracentrifugation 16%
• Percentage of Cells in S Phase 16%
• Lung 16%
• Proteinase 16%

Keyphrases

• In Vitro Antiproliferative Activity 50%